Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

13.38USD
8:01pm GMT
Change (% chg)

$-0.50 (-3.60%)
Prev Close
$13.88
Open
$13.83
Day's High
$13.83
Day's Low
$13.17
Volume
63,579
Avg. Vol
201,922
52-wk High
$20.85
52-wk Low
$9.60

Chart for

About

Alder BioPharmaceuticals, Inc., is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize genetically engineered therapeutic antibodies with the potential to meaningfully transform current treatment paradigms. Alder's lead pivotal-stage product candidate, eptinezumab, is being evaluated... (more)

Overall

Beta: 2.72
Market Cap(Mil.): $948.37
Shares Outstanding(Mil.): 68.33
Dividend: --
Yield (%): --

Financials

  ALDR.OQ Industry Sector
P/E (TTM): -- 81.01 29.57
EPS (TTM): -4.49 -- --
ROI: -68.19 -0.53 12.77
ROE: -119.26 -3.22 14.47

Earnings vs. Estimates